NGM Biopharmaceuticals Statistics

Total Valuation

NGM has a market cap or net worth of $128.53 million. The enterprise value is -$21.11 million.

Market Cap	128.53M
Enterprise Value	-21.11M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

NGM has 83.46 million shares outstanding. The number of shares has increased by 3.18% in one year.

Shares Outstanding	83.46M
Shares Change (YoY)	+3.18%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	21.08%
Owned by Institutions (%)	54.16%
Float	28.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.86
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.79, with zero debt.

Current Ratio	7.79
Quick Ratio	7.45
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -77.90% and return on invested capital (ROIC) is -104.87%.

Return on Equity (ROE)	-77.90%
Return on Assets (ROA)	-67.80%
Return on Capital (ROIC)	-104.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	138
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.81% in the last 52 weeks. The beta is 1.26, so NGM's price volatility has been higher than the market average.

Beta (1Y)	1.26
52-Week Price Change	-60.81%
50-Day Moving Average	1.55
200-Day Moving Average	1.53
Relative Strength Index (RSI)	48.54
Average Volume (30 Days)	1,070,739

Short Selling Information

The latest short interest is 1.68 million, so 2.01% of the outstanding shares have been sold short.

Short Interest	1.68M
Short Previous Month	1.63M
Short % of Shares Out	2.01%
Short % of Float	5.80%
Short Ratio (days to cover)	1.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-155.88M
Pretax Income	-142.38M
Net Income	-142.38M
EBITDA	-138.06M
EBIT	-142.38M
Earnings Per Share (EPS)	-$1.73

Full Income Statement

Balance Sheet

The company has $149.64 million in cash and no debt, giving a net cash position of $149.64 million or $1.79 per share.

Cash & Cash Equivalents	149.64M
Total Debt	n/a
Net Cash	149.64M
Net Cash Per Share	$1.79
Equity / Book Value	148.64M
Book Value Per Share	1.78
Working Capital	136.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$132.20 million and capital expenditures -$1.25 million, giving a free cash flow of -$133.45 million.

Operating Cash Flow	-132.20M
Capital Expenditures	-1.25M
Free Cash Flow	-133.45M
FCF Per Share	-$1.62

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NGM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.18%
Shareholder Yield	-3.18%
Earnings Yield	-110.77%
FCF Yield	-103.83%

Analyst Forecast

The average price target for NGM is $3.68, which is 138.96% higher than the current price. The consensus rating is "Buy".

Price Target	$3.68
Price Target Difference	138.96%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-9.85%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2